vs
Dorman Products, Inc.（DORM）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Dorman Products, Inc.的1.2倍（$622.0M vs $537.9M），Royalty Pharma plc净利率更高（34.4% vs 2.1%，领先32.3%），Royalty Pharma plc同比增速更快（4.8% vs 0.8%），过去两年Dorman Products, Inc.的营收复合增速更高（7.1% vs 4.6%）
多尔曼产品公司是美国知名的汽车售后配件制造商，成立于1918年，总部位于宾夕法尼亚州科尔马，在纳斯达克上市，股票代码为DORM，深耕汽车售后市场多年，为市场提供丰富的替换零部件产品。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
DORM vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$537.9M
营收增速更快
RPRX
高出4.0%
0.8%
净利率更高
RPRX
高出32.3%
2.1%
两年增速更快
DORM
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $537.9M | $622.0M |
| 净利润 | $11.6M | $214.2M |
| 毛利率 | 42.6% | — |
| 营业利润率 | 5.8% | 62.4% |
| 净利率 | 2.1% | 34.4% |
| 营收同比 | 0.8% | 4.8% |
| 净利润同比 | -78.8% | 2.9% |
| 每股收益（稀释后） | $0.38 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DORMRPRX
| Q4 25 | $537.9M | $622.0M | ||
| Q3 25 | $543.7M | $609.3M | ||
| Q2 25 | $541.0M | $578.7M | ||
| Q1 25 | $507.7M | $568.2M | ||
| Q4 24 | $533.8M | $593.6M | ||
| Q3 24 | $503.8M | $564.7M | ||
| Q2 24 | $503.0M | $537.3M | ||
| Q1 24 | $468.7M | $568.0M |
净利润DORMRPRX
| Q4 25 | $11.6M | $214.2M | ||
| Q3 25 | $76.4M | $288.2M | ||
| Q2 25 | $58.7M | $30.2M | ||
| Q1 25 | $57.5M | $238.3M | ||
| Q4 24 | $54.5M | $208.2M | ||
| Q3 24 | $55.3M | $544.0M | ||
| Q2 24 | $47.4M | $102.0M | ||
| Q1 24 | $32.8M | $4.8M |
毛利率DORMRPRX
| Q4 25 | 42.6% | — | ||
| Q3 25 | 44.4% | — | ||
| Q2 25 | 40.6% | — | ||
| Q1 25 | 40.9% | — | ||
| Q4 24 | 41.5% | — | ||
| Q3 24 | 40.5% | — | ||
| Q2 24 | 39.6% | — | ||
| Q1 24 | 38.7% | — |
营业利润率DORMRPRX
| Q4 25 | 5.8% | 62.4% | ||
| Q3 25 | 19.4% | 70.1% | ||
| Q2 25 | 15.2% | 36.3% | ||
| Q1 25 | 15.8% | 94.0% | ||
| Q4 24 | 16.3% | 60.9% | ||
| Q3 24 | 15.7% | — | ||
| Q2 24 | 14.4% | 50.2% | ||
| Q1 24 | 11.6% | -13.0% |
净利率DORMRPRX
| Q4 25 | 2.1% | 34.4% | ||
| Q3 25 | 14.1% | 47.3% | ||
| Q2 25 | 10.9% | 5.2% | ||
| Q1 25 | 11.3% | 41.9% | ||
| Q4 24 | 10.2% | 35.1% | ||
| Q3 24 | 11.0% | 96.3% | ||
| Q2 24 | 9.4% | 19.0% | ||
| Q1 24 | 7.0% | 0.8% |
每股收益（稀释后）DORMRPRX
| Q4 25 | $0.38 | $0.49 | ||
| Q3 25 | $2.48 | $0.67 | ||
| Q2 25 | $1.91 | $0.07 | ||
| Q1 25 | $1.87 | $0.55 | ||
| Q4 24 | $1.76 | $0.46 | ||
| Q3 24 | $1.80 | $1.21 | ||
| Q2 24 | $1.53 | $0.23 | ||
| Q1 24 | $1.05 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $49.4M | $618.7M |
| 总债务越低越好 | $440.6M | $9.0B |
| 股东权益账面价值 | $1.5B | $9.7B |
| 总资产 | $2.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.30× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资DORMRPRX
| Q4 25 | $49.4M | $618.7M | ||
| Q3 25 | $55.5M | $938.9M | ||
| Q2 25 | $56.8M | $631.9M | ||
| Q1 25 | $60.6M | $1.1B | ||
| Q4 24 | $57.1M | $929.0M | ||
| Q3 24 | $45.1M | $950.1M | ||
| Q2 24 | $47.5M | $1.8B | ||
| Q1 24 | $34.4M | $843.0M |
总债务DORMRPRX
| Q4 25 | $440.6M | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $468.8M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益DORMRPRX
| Q4 25 | $1.5B | $9.7B | ||
| Q3 25 | $1.5B | $9.6B | ||
| Q2 25 | $1.4B | $9.5B | ||
| Q1 25 | $1.3B | $9.8B | ||
| Q4 24 | $1.3B | $10.3B | ||
| Q3 24 | $1.2B | $10.3B | ||
| Q2 24 | $1.2B | $9.8B | ||
| Q1 24 | $1.2B | $9.9B |
总资产DORMRPRX
| Q4 25 | $2.5B | $19.6B | ||
| Q3 25 | $2.6B | $19.3B | ||
| Q2 25 | $2.5B | $18.3B | ||
| Q1 25 | $2.4B | $17.6B | ||
| Q4 24 | $2.4B | $18.2B | ||
| Q3 24 | $2.4B | $18.0B | ||
| Q2 24 | $2.3B | $17.7B | ||
| Q1 24 | $2.2B | $16.1B |
负债/权益比DORMRPRX
| Q4 25 | 0.30× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.36× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $33.5M | — |
| 自由现金流率自由现金流/营收 | 6.2% | — |
| 资本支出强度资本支出/营收 | 1.5% | — |
| 现金转化率经营现金流/净利润 | 3.60× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $75.7M | — |
8季度趋势，按日历期对齐
经营现金流DORMRPRX
| Q4 25 | $41.6M | $827.1M | ||
| Q3 25 | $12.2M | $702.6M | ||
| Q2 25 | $8.5M | $364.0M | ||
| Q1 25 | $51.2M | $596.1M | ||
| Q4 24 | $71.4M | $742.5M | ||
| Q3 24 | $44.3M | $703.6M | ||
| Q2 24 | $63.3M | $658.2M | ||
| Q1 24 | $52.0M | $664.6M |
自由现金流DORMRPRX
| Q4 25 | $33.5M | — | ||
| Q3 25 | $1.8M | — | ||
| Q2 25 | $98.0K | — | ||
| Q1 25 | $40.3M | — | ||
| Q4 24 | $63.2M | — | ||
| Q3 24 | $35.7M | — | ||
| Q2 24 | $51.4M | — | ||
| Q1 24 | $41.2M | — |
自由现金流率DORMRPRX
| Q4 25 | 6.2% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 11.8% | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 10.2% | — | ||
| Q1 24 | 8.8% | — |
资本支出强度DORMRPRX
| Q4 25 | 1.5% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 1.5% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 2.3% | — |
现金转化率DORMRPRX
| Q4 25 | 3.60× | 3.86× | ||
| Q3 25 | 0.16× | 2.44× | ||
| Q2 25 | 0.15× | 12.06× | ||
| Q1 25 | 0.89× | 2.50× | ||
| Q4 24 | 1.31× | 3.57× | ||
| Q3 24 | 0.80× | 1.29× | ||
| Q2 24 | 1.34× | 6.45× | ||
| Q1 24 | 1.58× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DORM
| Light Duty | $428.6M | 80% |
| Heavy Duty | $55.8M | 10% |
| Specialty Vehicle | $53.5M | 10% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
